172 related articles for article (PubMed ID: 2874413)
1. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.
Chiba S; Yokoyama T; Nakata S; Morita Y; Urasawa T; Taniguchi K; Urasawa S; Nakao T
Lancet; 1986 Aug; 2(8504):417-21. PubMed ID: 2874413
[TBL] [Abstract][Full Text] [Related]
2. Virological and serological aspects of immune resistance to rotavirus gastroenteritis.
Chiba S; Nakata S; Ukae S; Adachi N
Clin Infect Dis; 1993 Mar; 16 Suppl 2():S117-21. PubMed ID: 8384012
[TBL] [Abstract][Full Text] [Related]
3. Homotypic and heterotypic antibodies for prevention of experimental rotavirus gastroenteritis.
Losonsky GA; Vonderfecht SL; Eiden J; Wee SB; Yolken RH
J Clin Microbiol; 1986 Dec; 24(6):1041-4. PubMed ID: 3023437
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rhesus rotavirus vaccine MMU-18006 against gastroenteritis due to serotype 1 rotavirus.
Ukae S; Nakata S; Adachi N; Kogawa K; Chiba S
Vaccine; 1994 Aug; 12(10):933-9. PubMed ID: 7975835
[TBL] [Abstract][Full Text] [Related]
5. Maternal antibody-mediated protection against gastroenteritis due to rotavirus in newborn mice is dependent on both serotype and titer of antibody.
Offit PA; Clark HF
J Infect Dis; 1985 Dec; 152(6):1152-8. PubMed ID: 2999254
[TBL] [Abstract][Full Text] [Related]
6. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
[TBL] [Abstract][Full Text] [Related]
7. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
Green KY; Taniguchi K; Mackow ER; Kapikian AZ
J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
[TBL] [Abstract][Full Text] [Related]
8. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
Gorrell RJ; Bishop RF
J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibody immune response in children with primary and secondary rotavirus infections.
Arias CF; López S; Mascarenhas JD; Romero P; Cano P; Gabbay YB; de Freitas RB; Linhares AC
Clin Diagn Lab Immunol; 1994 Jan; 1(1):89-94. PubMed ID: 7496929
[TBL] [Abstract][Full Text] [Related]
10. Homotypic immune response to primary infection with rotavirus serotype G1.
Rojas AM; Boher Y; Guntiñas MJ; Pérez-Schael I
J Med Virol; 1995 Dec; 47(4):404-9. PubMed ID: 8636710
[TBL] [Abstract][Full Text] [Related]
11. Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype.
Gerna G; Sarasini A; Torsellini M; Torre D; Parea M; Battaglia M
J Infect Dis; 1990 Jun; 161(6):1105-11. PubMed ID: 2161039
[TBL] [Abstract][Full Text] [Related]
12. Epitope-specific immune responses to rotavirus vaccination.
Shaw RD; Fong KJ; Losonsky GA; Levine MM; Maldonado Y; Yolken R; Flores J; Kapikian AZ; Vo PT; Greenberg HB
Gastroenterology; 1987 Nov; 93(5):941-50. PubMed ID: 2443417
[TBL] [Abstract][Full Text] [Related]
13. Human immunity to rotavirus.
Molyneaux PJ
J Med Microbiol; 1995 Dec; 43(6):397-404. PubMed ID: 7473672
[TBL] [Abstract][Full Text] [Related]
14. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.
Brüssow H; Walther I; Fryder V; Sidoti J; Bruttin A
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1647-58. PubMed ID: 2839600
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of natural rotavirus infection.
Velázquez FR
Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S54-6. PubMed ID: 19252424
[TBL] [Abstract][Full Text] [Related]
16. Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections.
O'Ryan ML; Matson DO; Estes MK; Pickering LK
J Infect Dis; 1994 Mar; 169(3):504-11. PubMed ID: 8158022
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination.
Mrukowicz JZ; Thompson J; Reed GW; Tollefson SJ; Kobayashi M; Araki K; Wright PF
Vaccine; 1999 Feb; 17(7-8):745-53. PubMed ID: 10067679
[TBL] [Abstract][Full Text] [Related]
18. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
Clark HF; Borian FE; Plotkin SA
J Infect Dis; 1990 Jun; 161(6):1099-104. PubMed ID: 2161038
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of rotavirus gastroenteritis using immunoglobulin.
Ebina T
Arch Virol Suppl; 1996; 12():217-23. PubMed ID: 9015118
[TBL] [Abstract][Full Text] [Related]
20. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
